Profile
DXR ISRG BDXA BDX ALC RMD
Company Name Daxor Corporation Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $50.89M $183.74B $53.11B $49.57B $44.11B $40.72B
Employees 0.04K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Michael Richard Feldschuh Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
DXR ISRG BDXA BDX ALC RMD
Quant Rating Score 2 3 5 3 3 4
Quant Rating Sell Neutral Strong Buy Neutral Neutral Buy
Trading
DXR ISRG BDXA BDX ALC RMD
Last Close $9.45 $483.12 $59.24 $176.37 $87.87 $279.2
High 52 $10.26 $610.45 $59.24 $249.08 $100.76 $279.2
Low 52 $7.05 $438 $59.24 $165.15 $82.73 $204.58
Price vs. 52 Week High -7.89 % -20.86 % 0 % -29.19 % -12.79 % 0 %
Price vs. 52 Week Low 34.04 % 10.3 % 0 % 6.79 % 6.21 % 36.47 %
Total Return
DXR ISRG BDXA BDX ALC RMD
1 Month Return -2.98 % -10.65 % 0 % -0.51 % -1.6 % 9.09 %
3 Month Return 25.5 % -8.75 % 0 % 4.5 % -10.61 % 16.36 %
6 Month Return 22.97 % -15.52 % 0 % -28.77 % -3.53 % 18.21 %
9 Month Return 7.88 % -4.59 % 0 % -25.03 % -4.27 % 14.3 %
YTD Return 22.89 % -7.44 % 0 % -22.26 % 3.51 % 22.09 %
1 Year Return 20.23 % 7.42 % 0 % -27.08 % -4.88 % 24.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DXR ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.28 % 2.35 % 0.37 % 0.76 %
Dividend Paid and Capex Coverage Ration (TTM) -465343.67 % 2.77 % 1.77 % 1.77 % 3.43 % 4.21 %
Dividend Per Share (TTM) - - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) - - 76.77 % 76.77 % 11.23 % 23.14 %
Growth
DXR ISRG BDXA BDX ALC RMD
Asset Growth 5.06 % 21.38 % 8.54 % 8.54 % 1.79 %
Gross Profit Growth 1203.92 % 19.13 % 11.69 % 11.69 % 12.72 %
Revenue Growth 1203.92 % 17.24 % 4.16 % 4.16 % 10.95 %
Revenue 3 Year -69.49 % 46.64 % -0.51 % -0.51 % 44.86 %
Revenue 5 Year 1702.1 % 81.77 % 8.72 % 8.72 % 74.97 %
Revenue 10 Year 140.78 % 266.32 % 59.37 % 59.37 % 189.94 %
EBIT Growth 88.46 % 32.95 % 19.82 % 19.82 % 12.75 %
Net Income Growth 91.11 % 29.18 % 14.89 % 14.89 % 13.75 %
Net Income 3 Yeari Growth Per Share -90.58 % 36.6 % -18.63 % -18.63 % 112.66 %
Net Income 5 Yeari Growth Per Share 193.54 % 64.12 % 30.19 % 30.19 % 145.63 %
Net Income 10 Yeari Growth Per Share 142.6 % 418.52 % -4.02 % -4.02 % 184.54 %
Operating Income Growth 402.89 % 32.95 % 13.55 % 13.55 % 16.61 %
Operating Cash Flow Growth (CFG) 100.7 % 33.15 % 27.07 % 27.07 % 102.11 %
Operating 3 Year CFG 100.78 % 15.88 % -18.4 % -18.4 % 87.99 %
Operating 5 Year CFG -99.29 % 47.28 % 6.25 % 6.25 % 197.13 %
Operating 10 Year CFG 106.74 % 239.49 % 45.28 % 45.28 % 244.62 %
EPS Growth 81.52 % 27.71 % 18.31 % 18.31 % 13.4 %
EPS Diluted Growth 81.52 % 27.63 % 18.62 % 18.62 % 13.63 %
Book Value Per Share 0.65 % 21.99 % -0.85 % -0.85 % 17.57 %
Share Holder 3 Year Equity Growth Per Share 41.05 % 37.85 % 9.16 % 9.16 % 66.6 %
Share Holder 5 Year Equity Growth Per Share 142.4 % 93.34 % 13.89 % 13.89 % 128.49 %
Share Holder 10 Year Equity Growth Per Share 12.96 % 354.67 % 241.78 % 241.78 % 166.2 %
Dividend Per Share Growth - - -2.44 % -2.44 % 9.12 %
Dividend 3 Year Growth Per Share - - 4.79 % 4.79 % 23.08 %
Dividend 5 Year Growth Per Share - - 4.14 % 4.14 % 29.8 %
Dividend 10 Year Growth Per Share -100 % - 74.3 % 74.3 % 91.97 %
Debt Growth -100 % - 26.65 % 26.65 % -44.68 %
Free Cash Flow Growth 100.7 % 73.93 % 45.25 % 45.25 % 130 %
Updated On 31 Dec 2024 31 Dec 2024 30 Sep 2024 30 Sep 2024 30 Jun 2024
Profitability
DXR ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 90.27 % 67.09 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM 1.46 % 12.88 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM 1.57 % 15.52 % 5.86 % 5.86 % 5.22 % 25.18 %
Return on Capital Employed TTM 5.21 % 13.9 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM -49 % 88.31 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM -57.37 % 114.09 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM 248.71 % 28.2 % 11.33 % 11.33 % 15.24 % 32.1 %
Cash Flow To Debt Ratio TTM - - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM 79.26 6.46 6.89 6.89 5.34 5.53
Payables Turnover TTM - 10.39 - - 5.24 9.36
Inventory Turnover TTM - 1.85 3.11 3.11 1.88 2.41
Fixed Asset Turnover TTM - 181.6 % 313.98 % 313.98 % 202.43 % 729.93 %
Asset Turnover TTM 2.09 % 45.34 % 38.31 % 38.31 % 32.01 % 66.36 %
Operating Cash Flow Per Share TTM -0.28 7.64 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM -0.28 4.88 8.98 8.98 3.26 10.66
Cash Per Share TTM - 1261.9 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM -182 % 31.34 % 15.81 % 15.81 % 21.17 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 63.9 % 78.51 % 78.51 % 76.82 % 94.64 %
Cash Flow Coverage Ratios TTM - - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM -36.46 105.28 19.72 19.14 27.32 26.03
Price To Operating Cash Flows Ratio TTM -36.25 67.1 15.58 15.12 21.01 24.65
Price Cash Flow Ratio TTM -36.25 67.1 15.58 15.12 21.01 24.65
Income Statement (TTM)
DXR ISRG BDXA BDX ALC RMD
Revenue $0B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $0B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 100% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $0B $2.81B $4.82B $4.82B $2.68B $1.69B
Net Income $0B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted 0.11 6.42 5.86 5.86 2.05 -
Balance Sheet (MRQ)
DXR ISRG BDXA BDX ALC RMD
Long Term Debt $0B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0B $2.31B $31.4B $31.4B $8.79B $2.01B
Total Equity $0.04B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0.04B $7.05B $0.45B $0.45B $0.91B $0.17B
Total Debt $0B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.04B $18.84B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
DXR ISRG BDXA BDX ALC RMD
Net Income $0B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $0B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 87.87
ANGO AngioDynamics, Inc. 8.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 141.35
ATRC AtriCure, Inc. 34.41
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 32.34
BAX Baxter International Inc. 21.96
BDX Becton, Dickinson and Company 176.37
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 13.5
BLFS BioLife Solutions, Inc. 20.805
COO The Cooper Companies, Inc. 70.87
EKSO Ekso Bionics Holdings, Inc. 3.49
FEMY Femasys Inc. 0.8196
GCTK GlucoTrack, Inc. 6.23
ETFs With Exposure to DXR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00002 305.74
VTSAX Vanguard Total Stock Market Index Fund 0 148.89
VITSX Vanguard Total Stock Market Index Fund 0 148.91
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00002 279.34
Unlock